Scientists are exploring groundbreaking mRNA-based therapies as a potential new weapon against pancreatic cancer, one of the world’s deadliest and most difficult-to-treat cancers.
Researchers say mRNA technology — which gained global attention during the COVID-19 vaccine rollout — is now being adapted to help the immune system recognize and attack pancreatic tumor cells.
Early-stage studies suggest that personalized mRNA vaccines could train the body to target cancer mutations unique to each patient, improving the chances of stopping cancer growth or preventing recurrence after surgery.
Experts believe this approach may help overcome the cancer’s resilience, as pancreatic tumors often remain undetected until late stages and respond poorly to existing treatments like chemotherapy.
While research is still in clinical trial phases, scientists are hopeful that mRNA breakthroughs could significantly improve survival rates, offering new hope to patients worldwide.
Read More : Russian Scientists Reveal Breakthrough mRNA Cancer Vaccine
